These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 27923049)

  • 1. Expression of lncRNAs in Low-Grade Gliomas and Glioblastoma Multiforme: An In Silico Analysis.
    Reon BJ; Anaya J; Zhang Y; Mandell J; Purow B; Abounader R; Dutta A
    PLoS Med; 2016 Dec; 13(12):e1002192. PubMed ID: 27923049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular subtypes of glioblastoma are relevant to lower grade glioma.
    Guan X; Vengoechea J; Zheng S; Sloan AE; Chen Y; Brat DJ; O'Neill BP; de Groot J; Yust-Katz S; Yung WK; Cohen ML; Aldape KD; Rosenfeld S; Verhaak RG; Barnholtz-Sloan JS
    PLoS One; 2014; 9(3):e91216. PubMed ID: 24614622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
    Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
    Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Series of Nine Long Noncoding RNAs Associated with Survival of Patients with Glioblastoma.
    Lei B; Yu L; Jung TA; Deng Y; Xiang W; Liu Y; Qi S
    J Neurol Surg A Cent Eur Neurosurg; 2018 Nov; 79(6):471-478. PubMed ID: 29959764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
    Dahlrot RH
    Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA profiles reveal three molecular subtypes in glioma.
    Li R; Qian J; Wang YY; Zhang JX; You YP
    CNS Neurosci Ther; 2014 Apr; 20(4):339-43. PubMed ID: 24393335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
    Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
    Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CD40 Correlates Negatively with Overall and Progression-Free Survival of Low- and High-Grade Gliomas.
    Werner JM; Kuhl S; Ulrich K; Krischek B; Stavrinou P; Goldbrunner R; Timmer M
    World Neurosurg; 2019 Oct; 130():e17-e25. PubMed ID: 31125770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a Prognostic Hypoxia-Associated Gene Set in IDH-Mutant Glioma.
    Dao Trong P; Rösch S; Mairbäurl H; Pusch S; Unterberg A; Herold-Mende C; Warta R
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30257451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foreboding lncRNA markers of low-grade gliomas dependent on metabolism.
    Lu Z; Feng Y
    Medicine (Baltimore); 2022 Nov; 101(44):e31302. PubMed ID: 36343057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Prognostic Signature for Lower Grade Gliomas Based on Expression of Long Non-Coding RNAs.
    Kiran M; Chatrath A; Tang X; Keenan DM; Dutta A
    Mol Neurobiol; 2019 Jul; 56(7):4786-4798. PubMed ID: 30392137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
    Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY
    BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
    Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Over-expression of lysyl oxidase is associated with poor prognosis and response to therapy of patients with lower grade gliomas.
    Huang SP; Chiou J; Jan YH; Lai TC; Yu YL; Hsiao M; Lin YF
    Biochem Biophys Res Commun; 2018 Jun; 501(3):619-627. PubMed ID: 29729273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.
    Zhao J; Wang L; Wei B
    Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular profile of tumors with oligodendroglial morphology: Clinical relevance.
    Geevar T; Pai R; Chacko G; Malepathi K; Patel B; John J; Chacko AG; Balakrishnan R; John S
    Neurol India; 2018; 66(6):1726-1731. PubMed ID: 30504574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma.
    Gong Z; Hong F; Wang H; Zhang X; Chen J
    BMC Med Genet; 2020 Mar; 21(1):56. PubMed ID: 32188434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
    Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
    Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of an autophagy-related 10-lncRNA-mRNA signature for distinguishing glioblastoma multiforme from lower‑grade glioma and prognosis prediction.
    Wei B; Wang L; Zhao J
    Gen Physiol Biophys; 2021 Jul; 40(4):257-274. PubMed ID: 34350832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A glycolysis-based ten-gene signature correlates with the clinical outcome, molecular subtype and IDH1 mutation in glioblastoma.
    Chen C; Shi Y; Li Y; He ZC; Zhou K; Zhang XN; Yang KD; Wu JR; Kung HF; Ping YF; Bian XW
    J Genet Genomics; 2017 Nov; 44(11):519-530. PubMed ID: 29169920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.